Skip to content
  • Saturday, 15 August 2026
  • 12:26 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Cornell University Scientists Achieve Breakthrough in Developing Reversible and Nonhormonal Male Contraceptive Through Targeted Meiotic Interruption
Stem Cell & Regenerative Medicine

Cornell University Scientists Achieve Breakthrough in Developing Reversible and Nonhormonal Male Contraceptive Through Targeted Meiotic Interruption

Dwi Wanna Jul 13, 2026 0

In a landmark development for reproductive medicine, researchers at Cornell University have announced a significant advancement in the pursuit of…

Read More
Environmental & Analytical Chemistry

The developing brain is built through controlled DNA damage and rapid repair.

Abdurrohim Arsyad Jun 28, 2026 0

In a discovery that challenges conventional understanding of cellular integrity, new research indicates that the most perilous form of DNA…

Read More
Stem Cell & Regenerative Medicine

Cornell University Researchers Achieve Milestone in Developing Reversible Nonhormonal Male Contraceptive Targeting Meiosis

Dwi Wanna May 14, 2026 0

The pursuit of a reliable, reversible, and nonhormonal male contraceptive has long been described by the medical community as the…

Read More
Neuroscience & Brain Research

Mechanical Forces and Tissue Stiffness Identified as Primary Regulators of Chemical Signaling in the Developing Brain

Rifan Muazin Mar 22, 2026 0

The intricate process of brain development relies on the precise navigation of neurons as they extend axons—long, slender projections—to connect…

Read More
Lilly’s $7bn Acquisition of Kelonia Bears Fruit as In Vivo Cell Therapies Show Significant Promise at ASCO 2026Using Gemini to Create Google Sheets – KDnuggetsLabcorp and Children’s Hospital of Philadelphia Forge Alliance to Revolutionize Pediatric Diagnostics and Expand National AccessCaffeine Restores Social Memory Impaired by Sleep Deprivation According to New Research from NUS Medicine
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ